Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:45 AM
Ignite Modification Date:
2025-12-25 @ 1:45 AM
NCT ID:
NCT02443194
Eligibility Criteria:
Inclusion Criteria:
* Patients who signed an informed consent form
* Patients who underwent resection or biopsy for GBM
* KPS\> 70
Exclusion Criteria:
* Patients being treated with antidepressants
* Unable to answer the questionnaires because of an inability to communicate
* Patients being treated; monoamine oxidase inhibitors (MAOI) CYP1A2 Inhibitors or (CYP2D6 inhibitors (SSRIs such as fluoxetine, paroxetine, or anti-arrhythmia such as quinidine) Patients with Glaucoma, narrow angle
* Severe renal dysfunction. According to laboratory criteria specified earlier.
* Hepatic insufficiency - which laboratory criteria mentioned earlier.
* Pregnant women Patients Dementia
* Patients who previously suffered from depression in the past or within 5 years of diagnosis, and currently do not receive drug therapy
* Sensitivity to any of its ingredients
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT02443194
Study Brief:
Protocol Section:
NCT02443194